Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Monkhorst

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|March 10, 2020
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancerRobin M J M van Geel, Emilie M J van Brummelen, Ferry A L M Eskens, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung CancerTeodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancerMirte Muller, Myron G Best, Vincent van der Noort, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Cell|August 14, 2018
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsKrijn K Dijkstra, Chiara M Cattaneo, Fleur Weeber, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 17, 2022
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape projectLukas Bubendorf, Urania Dafni, Martin Schöbel, et al.
The Journal of Pathology|July 6, 2022
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practiceKris G Samsom, Luuk J Schipper, Paul Roepman, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2024
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape projectErnst-Jan M Speel, Urania Dafni, Erik Thunnissen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2023
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma DatabaseIsabelle Opitz, Andrea Bille, Urania Dafni, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|March 10, 2020
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancerRobin M J M van Geel, Emilie M J van Brummelen, Ferry A L M Eskens, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2021
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung CancerTeodora Radonic, W R R Geurts-Giele, Kris G Samsom, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancerMirte Muller, Myron G Best, Vincent van der Noort, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Cell|August 14, 2018
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsKrijn K Dijkstra, Chiara M Cattaneo, Fleur Weeber, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 17, 2022
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape projectLukas Bubendorf, Urania Dafni, Martin Schöbel, et al.
The Journal of Pathology|July 6, 2022
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practiceKris G Samsom, Luuk J Schipper, Paul Roepman, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2024
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape projectErnst-Jan M Speel, Urania Dafni, Erik Thunnissen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2023
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma DatabaseIsabelle Opitz, Andrea Bille, Urania Dafni, et al.
Pageof 11